Evidence map›Paper›PMID 38015461›Full record

ArticleImmunoHorizons2023

PD-1 Impairs CD8+ T Cell Granzyme B Production in Aged Mice during Acute Viral Respiratory Infection.

Olivia B Parks, Danielle Antos, Taylor Eddens, Sara Walters, Monika Johnson, Tim D Oury, Rachel A Gottschalk, John J Erickson, John V Williams

Open access · goldAbstract read
In one paragraph

Article in ImmunoHorizons, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Alarm Functions of PD-1+ Brain-Resident Memory T Cells.Journal of immunology (Baltimore, Md. : 1950) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Olivia B ParksDivision of Infectious Diseases, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Danielle AntosDivision of Pulmonology, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA.ORCID 0000-0002-8451-0600
Taylor EddensDivision of Allergy/Immunology, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Sara WaltersDivision of Infectious Diseases, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA.ORCID 0009-0003-6873-5943
Monika JohnsonDivision of Infectious Diseases, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Tim D OuryDepartment of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA.ORCID 0000-0002-4253-3214
Rachel A GottschalkDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA.ORCID 0000-0002-5248-8816
John J EricksonDivision of Neonatology and Pulmonary Biology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati School of Medicine, Cincinnati, OH.ORCID 0000-0001-6189-9302
John V WilliamsDivision of Infectious Diseases, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA.ORCID 0000-0001-8377-5175
University of Pittsburgh · USCincinnati Children's Hospital Medical Center · US

Funding

Pediatric Scientist Development Program (PSDP) [K12]K12HD000850 · NICHD · YALE UNIVERSITY · PI Sallie R. Permar · 1987 to 2026
$44.1M
TRAINING PROGRAM FOR MD/PHD STUDENTST32GM008208 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI STEINMAN, RICHARD A · 1987 to 2021
$15.4M
cGMP Manufacture, Fill-Finish, Release, Analytical and Stability Testing and Stability Program of a Nanoparticle Based HIV Envelope Vaccine75N93022D00005 · NIAID · INTERNATIONAL AIDS VACCINE INITIATIVE · PI HASSELL, THOMAS · 2022 to 2025
$8.0M
Host Determinants of Human Metapneumovirus Immunity and PathogenesisR01AI085062 · NIAID · VANDERBILT UNIVERSITY · PI John V. Williams · 2010 to 2026
$5.6M
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin75N92020D00005 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WATSON, KAROL E · 2020 to 2025
$5.1M
Linking steady-state cytokine signaling to alveolar macrophage function in homeostasis and lung infectionR01HL162658 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GOTTSCHALK, RACHEL A · 2022 to 2025
$2.4M
Age-dependent differences in the immune response to human metapneumovirusF30HL159915 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PARKS, OLIVIA · 2022 to 2025
$203k
Impact of interferon λ signaling on lung macrophage function and type 17 immunity during bacterial super-infection following influenzaF31HL164031 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ANTOS, DANIELLE · 2023 to 2024
$97k
NHLBI NIH HHS 75N92020D00005NHLBI NIH HHS F30 HL159915NHLBI NIH HHS F31 HL164031NHLBI NIH HHS R01 HL162658NIAID NIH HHS 75N93022D00005NIAID NIH HHS 75N93023D00005NIAID NIH HHS R01 AI085062NICHD NIH HHS K12 HD000850NIDA NIH HHS 75N95020D00005NIGMS NIH HHS T32 GM008208ORFDO NIH HHS 75N99020D00005
6 · The paper itself

Abstract

CD8+ T cell dysfunction contributes to severe respiratory viral infection outcomes in older adults. CD8+ T cells are the primary cell type responsible for viral clearance. With increasing age, CD8+ T cell function declines in conjunction with an accumulation of cytotoxic tissue-resident memory (TRM) CD8+ T cells. We sought to elucidate the role of PD-1 signaling on aged CD8+ T cell function and accumulation of CD8+ TRM cells during acute viral respiratory tract infection, given the importance of PD-1 regulating CD8+ T cells during acute and chronic infections. PD-1 blockade or genetic ablation in aged mice yielded improved CD8+ T cell granzyme B production comparable to that in young mice during human metapneumovirus and influenza viral infections. Syngeneic transplant and adoptive transfer strategies revealed that improved granzyme B production in aged Pdcd1-/- CD8+ T cells was primarily cell intrinsic because aged wild-type CD8+ T cells did not have increased granzyme B production when transplanted into a young host. PD-1 signaling promoted accumulation of cytotoxic CD8+ TRM cells in aged mice. PD-1 blockade of aged mice during rechallenge infection resulted in improved clinical outcomes that paralleled reduced accumulation of CD8+ TRM cells. These findings suggest that PD-1 signaling impaired CD8+ T cell granzyme B production and contributed to CD8+ TRM cell accumulation in the aged lung. These findings have implications for future research investigating PD-1 checkpoint inhibitors as a potential therapeutic option for elderly patients with severe respiratory viral infections.

Indexed as

Respiratory Tract InfectionsVirus DiseasesAnimalsCD8-Positive T-LymphocytesGranzymesHumansImmune Checkpoint InhibitorsMiceProgrammed Cell Death 1 ReceptorGranzymesImmune Checkpoint InhibitorsProgrammed Cell Death 1 Receptor

Identifiers

PMID38015461
PMCPMC10696419
OpenAlexW4389083087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.